Targeting inflammation to treat depression

September 3, 2012

Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of General Psychiatry.

"Inflammation is the body's natural response to infection or wounding, says Andrew H. Miller, MD, senior author for the study and professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine. "However when prolonged or excessive, inflammation can damage many parts of the body, including the brain."

Prior studies have suggested that depressed people with evidence of high inflammation are less likely to respond to traditional treatments for the disorder, including anti-depressant medications and psychotherapy. This study was designed to see whether blocking inflammation would be a useful treatment for either a wide range of people with difficult-to-treat depression or only those with high levels of inflammation.

The study employed infliximab, one of the new biologic drugs used to treat autoimmune and such as rheumatoid arthritis and . A biologic drug copies the effects of substances naturally made by the body's immune system. In this case, the drug was an antibody that blocks (TNF), a key molecule in inflammation that has been shown to be elevated in some .

Study participants all had and were moderately resistant to conventional antidepressant treatment. Each participant was assigned either to infliximab or to a non-active .

When investigators looked at the results for the group as a whole, no significant differences were found in the improvement of between the drug and placebo groups. However, when the subjects with high inflammation were examined separately, they exhibited a much better response to infliximab than to placebo.

Inflammation in this study was measured using a simple blood test that is readily available in most clinics and hospitals and measures C-reactive protein or CRP. The higher the CRP, the higher the inflammation, and the higher the likelihood of responding to the drug.

"The prediction of an antidepressant response using a simple blood test is one of the holy grails in psychiatry," says Miller. "This is especially important because the blood test not only measured what we think is at the root cause of depression in these patients, but also is the target of the drug."

"This is the first successful application of a biologic therapy to depression," adds Charles L. Raison, MD, first author of the study. "The study opens the door to a host of new approaches that target the immune system to treat psychiatric diseases." Raison, formerly at Emory, is now associate professor in the Department of Psychiatry at the University of Arizona College of Medicine – Tucson.

Explore further: Inflammation in depression: Chicken or egg?

Related Stories

Inflammation in depression: Chicken or egg?

January 5, 2012
An important ongoing debate in the field of psychiatry is whether inflammation in the body is a consequence of or contributor to major depression. A new study in Biological Psychiatry has attempted to resolve the issue.

Depression could be evolutionary byproduct of immune system

March 1, 2012
Depression is common enough – afflicting one in ten adults in the United States – that it seems the possibility of depression must be "hard-wired" into our brains. This has led biologists to propose several theories ...

Childhood adversity increases risk for depression and chronic inflammation

July 3, 2012
When a person injures their knee, it becomes inflamed. When a person has a cold, their throat becomes inflamed. This type of inflammation is the body's natural and protective response to injury.

Recommended for you

Babies can learn that hard work pays off

September 21, 2017
If at first you don't succeed, try, try again. A new study from MIT reveals that babies as young as 15 months can learn to follow this advice. The researchers found that babies who watched an adult struggle at two different ...

Oxytocin turns up the volume of your social environment

September 20, 2017
Before you shop for the "cuddle" hormone oxytocin to relieve stress and enhance your social life, read this: a new study from the University of California, Davis, suggests that sometimes, blocking the action of oxytocin in ...

Researchers develop new tool to assess individual's level of wisdom

September 20, 2017
Researchers at University of San Diego School of Medicine have developed a new tool called the San Diego Wisdom Scale (SD-WISE) to assess an individual's level of wisdom, based upon a conceptualization of wisdom as a trait ...

Alcohol use affects levels of cholesterol regulator through epigenetics

September 20, 2017
In an analysis of the epigenomes of people and mice, researchers at Johns Hopkins Medicine and the National Institutes of Health report that drinking alcohol may induce changes to a cholesterol-regulating gene.

Self-control may not diminish throughout the day

September 20, 2017
After a long day of work and carefully watching what you eat, you might expect your self-control to slip a little by kicking back and cracking open a bag of potato chips.

One in four girls is depressed at age 14, new study reveals

September 20, 2017
New research shows a quarter of girls (24%) and one in 10 boys (9%) are depressed at age 14.

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

jbone
5 / 5 (3) Sep 03, 2012
They seem to have pills for everything but when you want to know the actual cause of the inflammation you will be bounced around for years.
alfie_null
not rated yet Sep 04, 2012
They seem to have pills for everything but when you want to know the actual cause of the inflammation you will be bounced around for years.

Follow the money.

Preventing a malady - meh.

New medicine for malady - expensive but eventually pays out.

Repurposing an existing medicine (already been through the expensive approval process) - jackpot!

You also get bonus points if the treatment is chronic.
antonima
not rated yet Sep 04, 2012
Hey, isn't it a fact that people under chronic pain develop depression? And then they are saying 'if we can reduce pain [inflammation] our antidepressants are more likely to work'. Thats kind of obvious isn't it?

"Prior studies have suggested that depressed people with evidence of high inflammation are less likely to respond to traditional treatments for the disorder, including anti-depressant medications and psychotherapy."

Well duh, they are still in severe pain.

Thats just my take on it, I could be completely wrong. Inflammation and pain aren't necessarily in the same category of symptoms.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.